ALBIGER, NORA MARIA ELVIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.945
AS - Asia 1.203
EU - Europa 882
AF - Africa 284
SA - Sud America 224
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.578
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.820
SG - Singapore 343
CN - Cina 328
BR - Brasile 146
DE - Germania 136
HK - Hong Kong 131
IT - Italia 106
VN - Vietnam 94
FI - Finlandia 89
SE - Svezia 73
GB - Regno Unito 63
UA - Ucraina 46
NL - Olanda 34
FR - Francia 33
PL - Polonia 33
IN - India 29
RU - Federazione Russa 29
AT - Austria 24
KR - Corea 24
IE - Irlanda 21
TR - Turchia 20
MA - Marocco 17
AE - Emirati Arabi Uniti 15
JP - Giappone 15
BZ - Belize 14
CI - Costa d'Avorio 14
CO - Colombia 13
GR - Grecia 13
ID - Indonesia 13
PE - Perù 13
PH - Filippine 13
ZA - Sudafrica 13
AR - Argentina 12
BE - Belgio 12
GM - Gambi 12
PY - Paraguay 12
BB - Barbados 11
CR - Costa Rica 11
ES - Italia 11
MD - Moldavia 11
MX - Messico 11
NC - Nuova Caledonia 11
TH - Thailandia 11
DJ - Gibuti 10
KE - Kenya 10
KH - Cambogia 10
AL - Albania 9
BA - Bosnia-Erzegovina 9
BJ - Benin 9
BW - Botswana 9
CH - Svizzera 9
GH - Ghana 9
JO - Giordania 9
MK - Macedonia 9
RW - Ruanda 9
SO - Somalia 9
UY - Uruguay 9
AF - Afghanistan, Repubblica islamica di 8
AZ - Azerbaigian 8
BF - Burkina Faso 8
CA - Canada 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
EE - Estonia 8
ET - Etiopia 8
HU - Ungheria 8
IL - Israele 8
LY - Libia 8
ME - Montenegro 8
MG - Madagascar 8
NZ - Nuova Zelanda 8
RE - Reunion 8
TZ - Tanzania 8
YT - Mayotte 8
AD - Andorra 7
BY - Bielorussia 7
DK - Danimarca 7
IQ - Iraq 7
KG - Kirghizistan 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
MY - Malesia 7
NI - Nicaragua 7
NO - Norvegia 7
NP - Nepal 7
PK - Pakistan 7
PR - Porto Rico 7
PS - Palestinian Territory 7
SA - Arabia Saudita 7
SD - Sudan 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
ZM - Zambia 7
CD - Congo 6
CW - ???statistics.table.value.countryCode.CW??? 6
EC - Ecuador 6
GE - Georgia 6
GT - Guatemala 6
HR - Croazia 6
LC - Santa Lucia 6
Totale 6.340
Salva come PNG Salva come JPEG
Città #
Fairfield 571
Woodbridge 347
Ashburn 334
Chandler 334
Ann Arbor 322
Houston 252
Seattle 210
Singapore 209
Cambridge 207
Wilmington 187
Jacksonville 169
Hong Kong 123
Beijing 115
Boardman 70
Princeton 68
Dong Ket 64
Santa Clara 61
San Diego 50
Des Moines 38
Helsinki 34
Munich 34
Los Angeles 31
Padova 29
Medford 28
Nanjing 26
Frankfurt am Main 25
Hefei 25
Bytom 20
Roxbury 20
Seoul 16
Ho Chi Minh City 14
Turku 14
Abidjan 13
Nuremberg 13
Vienna 13
New York 12
Bridgetown 11
Dublin 11
Milan 11
Noumea 11
Redondo Beach 11
Athens 10
Belize City 10
Buffalo 10
Djibouti 10
London 10
Nanchang 10
Phnom Penh 10
Accra 9
Amman 9
Cotonou 9
Kigali 9
Antananarivo 8
Nairobi 8
Ouagadougou 8
San José 8
Shanghai 8
Tokyo 8
Andorra la Vella 7
Asunción 7
Baku 7
Casablanca 7
Gaborone 7
Istanbul 7
Jiaxing 7
Lima 7
Lusaka 7
Medellín 7
San Francisco 7
San Jose 7
Shenyang 7
São Paulo 7
Zhengzhou 7
Abu Dhabi 6
Auckland 6
Bangkok 6
Banjul 6
Bishkek 6
Brooklyn 6
Castries 6
Chennai 6
Chisinau 6
Dubai 6
Falls Church 6
Florence 6
Jinan 6
Lilongwe 6
Managua 6
Minsk 6
Panama City 6
Podgorica 6
Redwood City 6
Tallinn 6
Tashkent 6
Vientiane 6
Addis Ababa 5
Conakry 5
Dakar 5
Dar es Salaam 5
Dushanbe 5
Totale 4.569
Salva come PNG Salva come JPEG
Nome #
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 237
Diagnosis and complications of Cushing's disease: gender-related differences. 215
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 192
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 189
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 187
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 186
Early recognition of aggressive pituitary adenomas: a single-centre experience 182
Metyrapone treatment in Cushing’s syndrome: a real-life study 179
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 173
A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? 172
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 171
The Role of Unilateral Adrenalectomy in ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH). 165
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 165
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 163
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 161
Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia 160
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 159
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 158
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate 154
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 150
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 148
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 144
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 143
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 143
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 143
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 140
Therapeutic strategies for Cushing's syndrome: An update 139
Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules 139
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 137
Predicting late recurrence in surgically-treated patients with Cushing's disease. 134
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas 132
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 130
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 127
Effect of short term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerosis markers in hypopituitary patients with growth hormone deficiency. 126
Adrenal morpho-functional alterations in patients with acromegaly. 123
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. 119
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging 118
The role of the size in thyroid cancer risk stratification 116
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 111
Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. 107
Cyclic Cushing's syndrome: an overview. 99
Aterosclerosi extra coronaria nella sindrome di Cushing 95
Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary. 94
Sindrome di Cushing e rischio cardiovascolare 78
Corticotropin-releasing hormone test predicts the outcome of unilateral adrenalectomy in primary bilateral macronodular adrenal hyperplasia 76
Utilità  dell'uso dei test (DDAVP, CRH e 8 MG DEX OVERNIGHT) nell'indicazione chirurgica e nell'outcome della malattia di Cushing 76
Totale 6.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.348
article - articoli 21.631
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.979
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021494 0 0 0 53 15 27 13 50 79 93 66 98
2021/2022685 14 73 82 52 63 48 18 87 28 15 63 142
2022/2023583 125 89 6 89 78 71 1 36 54 3 26 5
2023/2024267 5 39 33 14 31 30 36 12 5 7 26 29
2024/20251.101 5 50 66 56 162 33 38 85 96 47 181 282
2025/20261.409 205 391 574 239 0 0 0 0 0 0 0 0
Totale 6.655